SANGUISYNC
LIVE

Serial Number

98874346

Owner

Shenzhen Beam Medical Technology Partnership Enterprise (Limited Partnership)

Attorney

Alistair Chan

First Use Date

Jul 19, 2024

Filing Date

Nov 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SANGUISYNC Trademark

Serial Number: 98874346 • Registration: 7889553

SANGUISYNC is a trademark filed by Shenzhen Beam Medical Technology Partnership Enterprise (Limited Partnership) on November 26, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Shenzhen Beam Medical Technology Partnership Enterprise (Limited Partnership)

B1301, Building 2, Tian'an Digital Innovation Park, Longcheng St.,Longgang Dist.
Shenzhen City 518000 , CN

Entity Type: 13

Trademark Details

Filing Date

November 26, 2024

Registration Date

August 12, 2025

First Use Anywhere

July 19, 2024

First Use in Commerce

July 19, 2024

Published for Opposition

June 24, 2025

Goods & Services

Hemoglobinometers; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Sphygmomanometers; Blood pressure measuring apparatus; Hematimeters; Sphygmotensiometers; Haemoglobinometers; Electronic sphygmomanometers; Stethoscopes and sphygmomanometers; Blood pressure monitors; Blood pressure transducers; Electronic wrist sphygmomanometers

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 12, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2025 CNSA
ASSIGNED TO EXAMINER
May 19, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 26, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 26, 2024 PARI
NEW APPLICATION ENTERED
Nov 26, 2024 NWAP
APPLICATION FILING RECEIPT MAILED
Nov 26, 2024 MAFR